PortfoliosLab logoPortfoliosLab logo
GTBP vs. NFLY
Performance
Return for Risk
Dividends
Drawdowns
Volatility

Performance

GTBP vs. NFLY - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in GT Biopharma, Inc. (GTBP) and YieldMax NFLX Option Income Strategy ETF (NFLY). The values are adjusted to include any dividend payments, if applicable.

Loading graphics...

GTBP vs. NFLY - Yearly Performance Comparison


2026 (YTD)202520242023
GTBP
GT Biopharma, Inc.
-48.03%-74.26%-60.13%-11.40%
NFLY
YieldMax NFLX Option Income Strategy ETF
3.21%1.66%66.37%3.45%

Returns By Period

In the year-to-date period, GTBP achieves a -48.03% return, which is significantly lower than NFLY's 3.21% return.


GTBP

1D
-1.50%
1M
-14.62%
YTD
-48.03%
6M
-30.42%
1Y
-81.02%
3Y*
-70.86%
5Y*
-71.46%
10Y*

NFLY

1D
1.57%
1M
-0.25%
YTD
3.21%
6M
-16.09%
1Y
1.97%
3Y*
5Y*
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

GTBP vs. NFLY — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

GTBP
GTBP Risk / Return Rank: 1111
Overall Rank
GTBP Sharpe Ratio Rank: 1212
Sharpe Ratio Rank
GTBP Sortino Ratio Rank: 99
Sortino Ratio Rank
GTBP Omega Ratio Rank: 1010
Omega Ratio Rank
GTBP Calmar Ratio Rank: 66
Calmar Ratio Rank
GTBP Martin Ratio Rank: 1717
Martin Ratio Rank

NFLY
NFLY Risk / Return Rank: 1414
Overall Rank
NFLY Sharpe Ratio Rank: 1414
Sharpe Ratio Rank
NFLY Sortino Ratio Rank: 1515
Sortino Ratio Rank
NFLY Omega Ratio Rank: 1515
Omega Ratio Rank
NFLY Calmar Ratio Rank: 1313
Calmar Ratio Rank
NFLY Martin Ratio Rank: 1313
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

GTBP vs. NFLY - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for GT Biopharma, Inc. (GTBP) and YieldMax NFLX Option Income Strategy ETF (NFLY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


GTBPNFLYDifference

Sharpe ratio

Return per unit of total volatility

-0.70

0.07

-0.77

Sortino ratio

Return per unit of downside risk

-1.15

0.31

-1.46

Omega ratio

Gain probability vs. loss probability

0.85

1.04

-0.19

Calmar ratio

Return relative to maximum drawdown

-0.93

0.05

-0.98

Martin ratio

Return relative to average drawdown

-1.24

0.10

-1.34

GTBP vs. NFLY - Sharpe Ratio Comparison

The current GTBP Sharpe Ratio is -0.70, which is lower than the NFLY Sharpe Ratio of 0.07. The chart below compares the historical Sharpe Ratios of GTBP and NFLY, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Loading graphics...

Sharpe Ratios by Period


GTBPNFLYDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

-0.70

0.07

-0.77

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

-0.60

Sharpe Ratio (All Time)

Calculated using the full available price history

-0.51

0.89

-1.40

Correlation

The correlation between GTBP and NFLY is 0.04, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


Dividends

GTBP vs. NFLY - Dividend Comparison

GTBP has not paid dividends to shareholders, while NFLY's dividend yield for the trailing twelve months is around 60.91%.


TTM202520242023
GTBP
GT Biopharma, Inc.
0.00%0.00%0.00%0.00%
NFLY
YieldMax NFLX Option Income Strategy ETF
60.91%61.53%49.91%11.84%

Drawdowns

GTBP vs. NFLY - Drawdown Comparison

The maximum GTBP drawdown since its inception was -99.99%, which is greater than NFLY's maximum drawdown of -37.18%. Use the drawdown chart below to compare losses from any high point for GTBP and NFLY.


Loading graphics...

Drawdown Indicators


GTBPNFLYDifference

Max Drawdown

Largest peak-to-trough decline

-99.99%

-37.18%

-62.81%

Max Drawdown (1Y)

Largest decline over 1 year

-89.26%

-37.18%

-52.08%

Max Drawdown (5Y)

Largest decline over 5 years

-99.93%

Current Drawdown

Current decline from peak

-99.99%

-23.36%

-76.63%

Average Drawdown

Average peak-to-trough decline

-92.35%

-7.37%

-84.98%

Ulcer Index

Depth and duration of drawdowns from previous peaks

66.91%

17.46%

+49.45%

Volatility

GTBP vs. NFLY - Volatility Comparison

GT Biopharma, Inc. (GTBP) has a higher volatility of 20.07% compared to YieldMax NFLX Option Income Strategy ETF (NFLY) at 4.66%. This indicates that GTBP's price experiences larger fluctuations and is considered to be riskier than NFLY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading graphics...

Volatility by Period


GTBPNFLYDifference

Volatility (1M)

Calculated over the trailing 1-month period

20.07%

4.66%

+15.41%

Volatility (6M)

Calculated over the trailing 6-month period

92.56%

22.24%

+70.32%

Volatility (1Y)

Calculated over the trailing 1-year period

116.65%

28.94%

+87.71%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

120.39%

28.39%

+92.00%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

127.76%

28.39%

+99.37%